October 2022

Lancet Respiratory Medicine

ACT: Colchicine and aspirin in community patients with COVID-19: an open-label, factorial, randomised, controlled trial

JW Eikelboom, SS Jolly, EP Belley-Cote, RP Whitlock, S Rangarajan, L Xu, L Heenan, SI Bangdiwala, WM Tarhuni, M Hassany, A Kontsevaya, W Harper, SK Sharma, P Lopez-Jaramillo, AL Dans, LM Palileo-Villanueva, A Avezum, P Pais, D Xavier, C Felix, A Yusufali, RD Lopes, O Berwanger, Z Ali, S Wasserman, SS Anand, J Bosch, S Choudhri, ME Farkouh, M Loeb, S Yusuf

Read More

October 2022

Lancet Respiratory Medicine

ACT: Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19: an open-label, factorial, randomised, controlled trial

J Eikelboom, SS Jolly, EP Belley-Cote, RP Whitlock, S Rangarajan, L Xu, L Heenan, SI Bangdiwala, ML Diaz, R Diaz, A Yusufali, SK Sharma, WM Tarhuni, M Hassany, A Avezum, W Harper, S Wasserman, A Almas, O Drapkina, C Felix, RD Lopes, O Berwanger, P Lopez-Jaramillo, SS Anand, J Bosch, S Choudhri, S Choudhri, ME Farkouh, M Loeb, S Yusuf

Read More

September 2022

JAMA Cardiology

COMPLETE: Complete revascularization vs culprit lesion–only percutaneous coronary intervention for angina-related quality of life in patients with ST-segment elevation myocardial infarction

SR Mehta, J Wang, DA Wood, JA Spertus, DJ Cohen, R Mehran, RF Storey, PG Steg, N Pinilla-Echeverri, T Sheth, KR Bainey, S Bangalore, WJ Cantor, DP Faxon, LJ Feldman, SS Jolly, V Kunadian, S Lavi, J Lopez-Sendon, M Madan, R Moreno, SV Rao, J Rodes-Cabau, G Stankovic, SI Bangdiwala, JA Cairns

Read More

Back To Top